Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.
about
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Agalsidase alfa versus agalsid ...... an international cohort study.
@en
Agalsidase alfa versus agalsid ...... an international cohort study.
@nl
type
label
Agalsidase alfa versus agalsid ...... an international cohort study.
@en
Agalsidase alfa versus agalsid ...... an international cohort study.
@nl
prefLabel
Agalsidase alfa versus agalsid ...... an international cohort study.
@en
Agalsidase alfa versus agalsid ...... an international cohort study.
@nl
P2093
P2860
P1476
Agalsidase alfa versus agalsid ...... an international cohort study
@en
P2093
André B P van Kuilenburg
Aneal Khan
Atul Mehta
Carla E M Hollak
Christoph Wanner
Daniel G Bichet
Daniel Oder
Derralynn A Hughes
Frédéric M Vaz
Marieke Biegstraaten
P2860
P304
P356
10.1136/JMEDGENET-2017-104863
P407
P577
2018-02-07T00:00:00Z